On April 10, 2024, Intellia Therapeutics, Inc. appointed Michael P. Dube, 46, as principal accounting officer of the Company. Mr. Dube joined the Company in September 2023 and is currently the Vice President, Chief Accounting Officer of the Company. Prior to Intellia, Mr. Dube was with Abiomed, Inc. from 2012 to 2023, serving in several finance and accounting roles of increasing responsibility, ultimately holding the position of Global Corporate Controller.

Mr. Dube is a certified public accountant and began his career in public accounting at Deloitte & Touche LLP, where he spent 10 years within the audit & assurance practice .